Elk Creek Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $17.9M | Buy |
394,740
+15,050
| +4% | +$683K | 3.08% | 3 |
|
|
2019
Q4 | $24.7M | Sell |
379,690
-167,821
| -31% | -$10.9M | 2.84% | 3 |
|
|
2019
Q3 | $34M | Buy |
547,511
+161,012
| +42% | +$10M | 2.92% | 4 |
|
|
2019
Q2 | $27.5M | Buy |
386,499
+50,153
| +15% | +$3.57M | 2.06% | 5 |
|
|
2019
Q1 | $26.4M | Buy |
336,346
+188,896
| +128% | +$14.8M | 1.9% | 6 |
|
|
2018
Q4 | $12.5M | Buy |
147,450
+46,039
| +45% | +$3.9M | 1.04% | 32 |
|
|
2018
Q3 | $17.4M | Sell |
101,411
-34,977
| -26% | -$5.99M | 0.94% | 37 |
|
|
2018
Q2 | $17.6M | Sell |
136,388
-26,406
| -16% | -$3.41M | 0.97% | 34 |
|
|
2018
Q1 | $16.8M | Sell |
162,794
-53,050
| -25% | -$5.47M | 0.98% | 32 |
|
|
2017
Q4 | $18.4M | Buy |
215,844
+6,003
| +3% | +$513K | 1.08% | 28 |
|
|
2017
Q3 | $17.8M | Sell |
209,841
-4,612
| -2% | -$392K | 1.12% | 29 |
|
|
2017
Q2 | $16.2M | Sell |
214,453
-21,889
| -9% | -$1.66M | 1.05% | 31 |
|
|
2017
Q1 | $15.6M | Buy |
236,342
+53,057
| +29% | +$3.5M | 0.95% | 40 |
|
|
2016
Q4 | $11.6M | Sell |
183,285
-15,970
| -8% | -$1.01M | 0.78% | 51 |
|
|
2016
Q3 | $12.7M | Buy |
+199,255
| New | +$12.7M | 0.84% | 46 |
|